Glycemic Impact of Meal-Dosing Behavior in Users of the InPen Smart Insulin Pen (SIP) Paired with Continuous Glucose Monitoring (CGM)

被引：0
|
作者：
Macleod, Janice
Smith, Madison
Im, Glen Heungyong
Cordero, Toni L.
Vigersky, Robert A.
机构：
来源：
DIABETES | 2023年 / 72卷
关键词：
D O I：
10.2337/db23-58-OR
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
58-OR
引用
收藏
页数：2
相关论文
共 50 条
  • [21] EFFECT OF TIRZEPATIDE VERSUS INSULIN DEGLUDEC ON GLYCEMIC CONTROL CAPTURED WITH CONTINUOUS GLUCOSE MONITORING IN PATIENTS WITH TYPE 2 DIABETES (SURPASS-3 CGM)
    Battelino, T.
    Bergenstal, R.
    Rodriguez, A.
    Lando, L. Fernandez
    Bray, R.
    Tong, Z.
    Brown, K.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2022, 24 : A37 - A38
  • [22] Real Time Continuous Glucose Monitoring (RT-CGM) Users Make Significant Adjustments to Insulin Doses Based on CGM Rate of Change Arrows: Comparison between Users with Type 1 and Type 2 Diabetes
    Edelman, Steven V.
    Pettus, Jeremy
    Price, David A.
    DIABETES, 2014, 63 : A213 - A213
  • [23] Real-World Life Analysis of a Continuous Glucose Monitoring and Smart Insulin Pen System in Type 1 Diabetes: A Cohort Study
    Pantanetti, Paola
    Cangelosi, Giovanni
    Morales Palomares, Sara
    Ferrara, Gaetano
    Biondini, Federico
    Mancin, Stefano
    Caggianelli, Gabriele
    Parozzi, Mauro
    Sguanci, Marco
    Petrelli, Fabio
    DIABETOLOGY, 2025, 6 (01):
  • [24] Simulating the glycaemic impact of meal insulin dose determinations using continuous glucose monitoring vs self-monitored blood glucose
    Price, D.
    Nandagopalan, S.
    DIABETOLOGIA, 2014, 57 : S390 - S391
  • [25] Efficacy of Additional Canagliflozin Administration to Type 2 Diabetes Patients Receiving Insulin Therapy: Examination of Diurnal Glycemic Patterns Using Continuous Glucose Monitoring (CGM)
    Matsumura, Mihoko
    Nakatani, Yuki
    Tanka, Seiichi
    Aoki, Chie
    Sagara, Masaaki
    Yanagi, Kazunori
    Suzuki, Kunihiro
    Aso, Yoshimasa
    DIABETES THERAPY, 2017, 8 (04) : 821 - 827
  • [26] Efficacy of Additional Canagliflozin Administration to Type 2 Diabetes Patients Receiving Insulin Therapy: Examination of Diurnal Glycemic Patterns Using Continuous Glucose Monitoring (CGM)
    Mihoko Matsumura
    Yuki Nakatani
    Seiichi Tanka
    Chie Aoki
    Masaaki Sagara
    Kazunori Yanagi
    Kunihiro Suzuki
    Yoshimasa Aso
    Diabetes Therapy, 2017, 8 : 821 - 827
  • [27] HOW PEOPLE USE DIRECTION AND RATE OF CHANGE INFORMATION PROVIDED BY REAL-TIME CONTINUOUS GLUCOSE MONITORING (RT-CGM) TO ADJUST INSULIN DOSING
    Pettus, J.
    Price, D. A.
    Hill, K. J.
    Edelman, S.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2014, 16 : A76 - A77
  • [28] IMPACT OF COVID-19 PANDEMIC ON PROVISION OF CONTINUOUS SUBCUTANEOUS INSULIN INFUSION (CSII) AND CONTINUOUS GLUCOSE MONITORING (CGM) STARTS AND RENEWALS IN THE UNITED KINGDOM (UK)
    Forde, H.
    Choudhary, P.
    Hussain, S.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2021, 23 : A198 - A199
  • [29] BUDGET IMPACT ANALYSIS (BIA) OF ADOPTING REALTIME CONTINUOUS GLUCOSE MONITORING (RT-CGM) VS INTERMITTENT-SCANNING CONTINUOUS GLUCOSE MONITORING (IS-CGM) IN PATIENTS WITH TYPE 1 DIABETES ON INSULIN THERAPY (PWT1D) IN ITALY
    Ilham, S.
    Alshannaq, H.
    Norman, G.
    Lynch, P.
    VALUE IN HEALTH, 2023, 26 (12) : S173 - S173
  • [30] Erratum to: Efficacy of Additional Canagliflozin Administration to Type 2 Diabetes Patients Receiving Insulin Therapy: Examination of Diurnal Glycemic Patterns Using Continuous Glucose Monitoring (CGM)
    Mihoko Matsumura
    Yuki Nakatani
    Seiichi Tanka
    Chie Aoki
    Masaaki Sagara
    Kazunori Yanagi
    Kunihiro Suzuki
    Yoshimasa Aso
    Diabetes Therapy, 2017, 8 : 1437 - 1437
12345